MLEC Earnings Prediction
The chart below shows how MLEC performed 10 days before and after its earnings report, based on data from the past quarters. Typically, MLEC sees a +4.33% change in stock price 10 days leading up to the earnings, and a -4.81% change 10 days following the report. On the earnings day itself, the stock moves by -3.09%. This data can give you a slight idea of what to expect for the next quarter's release.
MLEC Key Earning Data
2024/Q4
Year Over Year
Quarter Over Quarter
Total Revenue
1.52M
68.29%
-27.81%
Gross Margin
-4.70%
-70.31%
-287.25%
Operating Margin
-193.02%
218.57%
99.44%
Net Margin
-166.46%
-45.18%
150.47%
EPS
-0.07
-36.36%
75.00%
No Data Available
MLEC Earnings Analysis
Moolec Science SA Ordinary Shares Corporation (MLEC.O) Earnings Conference Call
Positive
Quarterly Business Highlights: Moolect announced its fourth quarter and full fiscal year 2024 business highlights.
Revenue Increase Year-Over-Year: Normalized revenues increased by $4.8 million year-over-year from approximately $1 million in 2023 to $5.8 million in 2024.
Significant Revenue Growth: Moolect's Chief Financial Officer walked through the financial overview, highlighting significant revenue growth.
Product Development Success: The company achieved significant results in the continued development of Piggy Sooy product.
Exceptional Team Execution: Moolect's team has shown exceptional execution, leading to a successful year in scientific developments and business operations.
Negative
Revenue Increase Analysis: Normalized revenues and other income increased by $4.8 million year-over-year from approximately $1 million in 2023 to $5.8 million in 2024, primarily due to the consolidation of the soy product ingredient business.
Cost of Sales Increase: Normalized cost of sales increased from close to $1 million in 2023 to $4.5 million in 2024, aligning with revenue growth and resulting in an annual gross margin of around indiscernible.
Expense Increase Analysis: SG&A and R&D expenses increased by $3.1 million, from $6.2 million in 2023 to $9.3 million in 2024, mainly related to non-cash items such as depreciation, amortization, and equity incentives.
Increased Operating Costs: Cash utilized in operating activities increased by $1.8 million, from $7.5 million in 2023 to $9.3 million in 2024, indicating higher operational costs.
Cash Position and Soybean Purchase: The cash position of approximately $5.4 million as of Q4 2024 has been complemented with the purchase of 15,000 tons of HB4 soybeans, which has strategic value for the company.
MLEC FAQs
How does MLEC typically perform around its earnings report dates?
Is Moolec Science (MLEC) Q4 2024 Earnings Call Summary positive or negative?
How can historical earnings data help predict future stock performance?
MLEC Earning Call Sentiment
Moolec Science (MLEC) Q4 2024 Earnings Call Transcript
1.0x
00:00
00:00
MLEC.O
5.88%Positive
The earnings call presents a mixed picture. While there are positive developments like the collaboration with a major CPG company and Bunge, and revenue growth, there are significant concerns. Financial risks are evident with increased cash utilization and reliance on convertible notes. Operational risks and competitive pressures also loom large. The Q&A section highlighted some positive partnerships but lacked clarity on revenue specifics, adding uncertainty. Overall, these factors balance each other, leading to a neutral sentiment with potential for minor fluctuations in stock price.
